Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 24, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-10-26
DOI
10.1080/15384047.2023.2269637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
- (2022) Denise M. Wolf et al. CANCER CELL
- ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis
- (2021) Jeffrey M. Granja et al. NATURE GENETICS
- Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
- (2021) Cristina Capuano et al. Cancers
- Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
- (2020) E. Martinelli et al. ANNALS OF ONCOLOGY
- Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
- (2020) Shelly Kalaora et al. Nature Communications
- Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
- (2020) Tetsuaki Shoji et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- (2020) Sandra M Swain et al. LANCET ONCOLOGY
- Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity
- (2020) Mariko Nishie et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mechanisms of natural killer cell‐mediated cellular cytotoxicity
- (2019) Isabel Prager et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
- (2019) Breanna L. Zerfas et al. JOURNAL OF MEDICINAL CHEMISTRY
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers
- (2018) Ian MacFawn et al. MOLECULAR IMMUNOLOGY
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- A Mechanism of Resistance to Antibody-Targeted Immune Attack
- (2018) Dalal S Aldeghaither et al. Cancer Immunology Research
- EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
- (2017) Yasuyuki Okada et al. MOLECULAR CANCER RESEARCH
- New insights into the role of EMT in tumor immune escape
- (2017) Stéphane Terry et al. Molecular Oncology
- The effect of different anesthetics on tumor cytotoxicity by natural killer cells
- (2017) Kazumasa Tazawa et al. TOXICOLOGY LETTERS
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Trastuzumab in the Treatment of Breast Cancer
- (2016) Sofia Maximiano et al. BIODRUGS
- Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K 521 Polymorphism
- (2016) Friederike Braig et al. CANCER RESEARCH
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab
- (2016) Martín Granados-García et al. ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery
- Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
- (2016) Vincenzo Sforza et al. WORLD JOURNAL OF GASTROENTEROLOGY
- X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity
- (2016) M K Evans et al. Cell Death & Disease
- The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients
- (2015) Martino Monteverde et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
- (2015) Sandra Schmitz et al. Oncotarget
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
- (2015) Loredana Cifaldi et al. Arthritis & Rheumatology
- Cetuximab-mediated ADCC activity is correlated with the cell surface expression level of EGFR but not with the KRAS/BRAF mutational status in colorectal cancer
- (2014) YUKI SEO et al. ONCOLOGY REPORTS
- c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity
- (2014) J. C. Murray et al. Cancer Immunology Research
- HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
- (2013) Ji-Won Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- HER2-positive gastric cancer
- (2013) Narikazu Boku Gastric Cancer
- Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma
- (2012) J. G. Einspahr et al. Cancer Prevention Research
- Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth
- (2012) N. N. Khodarev et al. CLINICAL CANCER RESEARCH
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
- (2011) Toni M. Brand et al. CANCER BIOLOGY & THERAPY
- Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy
- (2011) P. Hubert et al. CANCER RESEARCH
- Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux�) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
- (2011) Javier Menendez INTERNATIONAL JOURNAL OF ONCOLOGY
- Epidermal Growth Factor Receptor (EGFR) Antibody-Induced Antibody-Dependent Cellular Cytotoxicity Plays a Prominent Role in Inhibiting Tumorigenesis, Even of Tumor Cells Insensitive to EGFR Signaling Inhibition
- (2011) M. B. Overdijk et al. JOURNAL OF IMMUNOLOGY
- The DNA Damage Response Induces IFN
- (2011) Sabrina Brzostek-Racine et al. JOURNAL OF IMMUNOLOGY
- Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts
- (2010) Mothaffar F. Rimawi et al. CLINICAL CANCER RESEARCH
- Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
- (2010) Robert L. Ferris et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells
- (2009) S. Benavente et al. CLINICAL CANCER RESEARCH
- Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response
- (2009) Yong-Wei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now